| Eligibility for the subcutaneous implantable cardioverter‐defibrillator in patients with hypertrophic cardiomyopathy P Francia, C Adduci, F Palano, L Semprini, A Serdoz, D Montesanti, ... Journal of cardiovascular electrophysiology 26 (8), 893-899, 2015 | 49 | 2015 |
| Osteopontin and galectin‐3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators P Francia, C Adduci, L Semprini, M Borro, A Ricotta, I Sensini, D Santini, ... Journal of cardiovascular electrophysiology 25 (6), 609-616, 2014 | 47 | 2014 |
| Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study P Francia, M Biffi, C Adduci, L Ottaviano, F Migliore, S De Bonis, ... EP Europace 22 (12), 1822-1829, 2020 | 39 | 2020 |
| Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy MB Musumeci, V Mastromarino, M Casenghi, G Tini, P Francia, A Maruotti, ... International Journal of Cardiology 248, 326-332, 2017 | 32 | 2017 |
| Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic … P Francia, M Ziacchi, P De Filippo, S Viani, A D’Onofrio, V Russo, ... Journal of Interventional Cardiac Electrophysiology 52, 61-67, 2018 | 30 | 2018 |
| Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter‐defibrillator in patients with hypertrophic cardiomyopathy P Francia, D Santini, B Musumeci, L Semprini, C Adduci, E Pagannone, ... Journal of cardiovascular electrophysiology 25 (11), 1180-1187, 2014 | 27 | 2014 |
| P‐wave duration in lead aVR and the risk of atrial fibrillation in hypertension P Francia, A Ricotta, C Balla, C Adduci, L Semprini, A Frattari, ... Annals of Noninvasive Electrocardiology 20 (2), 167-174, 2015 | 24 | 2015 |
| Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge B Musumeci, G Tini, D Russo, M Sclafani, F Cava, A Tropea, C Adduci, ... Journal of Clinical Medicine 10 (8), 1547, 2021 | 20 | 2021 |
| Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy P Francia, C Adduci, L Semprini, F Palano, D Santini, B Musumeci, ... Journal of cardiovascular electrophysiology 28 (1), 103-108, 2017 | 19 | 2017 |
| Safety, efficacy and evidence base for use of the subcutaneous implantable cardioverter defibrillator C Adduci, F Palano, P Francia Journal of Clinical Medicine 7 (3), 53, 2018 | 17 | 2018 |
| Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure P Francia, C Adduci, A Ricotta, R Stanzione, I Sensini, A Uccellini, ... Journal of Interventional Cardiac Electrophysiology 38, 169-177, 2013 | 17 | 2013 |
| Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the covid‐19 lockdown M Magnocavallo, A Bernardini, MV Mariani, A Piro, M Marini, A Nicosia, ... Pacing and Clinical Electrophysiology 44 (6), 995-1003, 2021 | 15 | 2021 |
| Safety and efficacy of anti‐tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD C Adduci, L Semprini, F Palano, MB Musumeci, M Volpe, C Autore, ... Pacing and Clinical Electrophysiology 42 (6), 610-616, 2019 | 14 | 2019 |
| Long-term left ventricular remodeling of patients with hypertrophic cardiomyopathy MB Musumeci, D Russo, LR Limite, M Canepa, G Tini, M Casenghi, ... The American Journal of Cardiology 122 (11), 1924-1931, 2018 | 14 | 2018 |
| Atrial natriuretic peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation P Francia, A Ricotta, A Frattari, R Stanzione, A Modestino, F Mercanti, ... Clinical Medicine Insights: Cardiology 7, CMC. S12239, 2013 | 11 | 2013 |
| Novel imaging and genetic risk markers in takotsubo syndrome L Arcari, LR Limite, C Adduci, M Sclafani, G Tini, F Palano, P Cosentino, ... Frontiers in Cardiovascular Medicine 8, 703418, 2021 | 10 | 2021 |
| Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter? P Francia, F Palano, G Tocci, C Adduci, A Ricotta, L Semprini, ... International Scholarly Research Notices 2014 (1), 652421, 2014 | 10 | 2014 |
| Acute shock efficacy of the subcutaneous implantable cardioverter‐defibrillator according to the implantation technique P Francia, C Adduci, A Angeletti, L Ottaviano, L Perrotta, S De Vivo, ... Journal of Cardiovascular Electrophysiology 32 (6), 1695-1703, 2021 | 9 | 2021 |
| Assessing atrial fibrillation substrates by P wave analysis: a comprehensive review F Palano, C Adduci, P Cosentino, G Silvetti, F Boldini, P Francia High Blood Pressure & Cardiovascular Prevention 27 (5), 341-347, 2020 | 9 | 2020 |
| RyR2 common gene variant G1886S and the risk of ventricular arrhythmias in ICD patients with heart failure P Francia, C Adduci, L Semprini, R Stanzione, A Serdoz, M Caprinozzi, ... Journal of Cardiovascular Electrophysiology 26 (6), 656-661, 2015 | 7 | 2015 |
